Cancer Care Ontario | Cancer Care Ontario

The New Drug Funding Program (NDFP) and pays for many newer, and often very expensive, injectable cancer drugs administered in hospitals and cancer...

Drug Funding Frequently Asked Questions

We’ve compiled the answers to many commonly asked questions about cancer drug costs and funding in Ontario.

Symptom Management

Dyspnea (Shortness of Breath)

Symptom Management

Nausea and Vomiting

Symptom Management

Neoadjuvant or Adjuvant Therapy for Resectable Gastric Cancer

Dasatinib for the Treatment of Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

Docetaxel plus Cyclophosphamide as Adjuvant Therapy for Early, Operable Breast Cancer

Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Dose-intensive Chemotherapy with Growth Factor or Autologous Bone Marrow/Stem Cell Transplant Support in Advanced or Metastatic Adult Soft Tissue Sarcoma

Doxorubicin-Based Chemotherapy for the Palliative Treatment of Adult Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma

Diagnostic Imaging in Breast Cancer

New Drug Funding Program

Drug Funding Frequently Asked Questions

Dyspnea (Shortness of Breath)

Nausea and Vomiting

Delirium

Pages